We assessed hepatitis A and hepatitis B vaccination series completion rates among 350,240 commercial/Medicare and 12,599 Medicaid enrollees aged ≥19 years. A vaccination series was considered as completed provided that the minimum interval between doses, as defined by the CDC, and the minimum ...
Hepatitis B virus (HBV) belongs to an ancient family of hepatotropic DNA viruses, with origins dating back millions of years1, and still poses a major health burden to humans nowadays2,3. HBV infection can lead to both acute and chronic diseases, elevating the risk of cirrhosis and liver c...
Recommendation 2: Catch-up vaccination should be administered for children who have not been vaccinated with the hepatitis B vaccine or who have not completed the full vaccination series. The interval between the first dose and the second dose should be ≥28 days, and the interval between the ...
Infants who fail to respond to an initial HepB series and are not infected should be revaccinated with an additional HepB dose and have anti-HBs testing 1–2 months later. Infants whose anti-HBs remains <10 mIU/mL should receive 2 additional HepB doses to complete the second series, ...
to elicit dose-specific and final rates of seroprotection similar to those obtained on a 0-, 1-, and 6-month schedule.33Minimum intervals between doses should always be respected (Table 11.3), but prolonging the interval does not alter theimmunogenicityor necessitate restarting the series. ...
Hepatitis B seroconversion panels 26022-14518, 13867-3482, 1807-3463, 43527-3453, and 0994–3457 were purchased from North American Biologicals, Inc. (Boca Raton, FL). The panels are series of longitudinal samples from five plasmapheresis donors identified as having acute HBV infection. All were...
This small series of patients is a little different in that these grafts have been used in all recipients regardless of their recipient serologic status. Some centers have utilized hepatitis B core–positive antibody grafts but have restricted those to patients in whom the recipients were chronic he...
Hepatitis B virus (HBV) is endemic in sub-Saharan Africa, and despite the introduction of universal hepatitis B vaccination and effective antiviral therapy, the estimated overall seroprevalence of hepatitis B surface antigen remains high at 6·1% (95% uncertainty interval 4·6-8·5). In this ...
The ensuing discussion will focus on Engerix B paediatric formulation [25]. Preparation/dilution No dilution required. Shake vigorously before use. Dosage/interval -0.5 mL IM -Should be given to all infants as soon as possible after birth -The greatest benefit is seen when the first dose is ...
to elicit dose-specific and final rates of seroprotection similar to those obtained on a 0-, 1-, and 6-month schedule.33Minimum intervals between doses should always be respected (Table 11.3), but prolonging the interval does not alter theimmunogenicityor necessitate restarting the series. ...